A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies. The RAN is a consortium comprising researchers from the UCSF School of Pharmacy (UCSF Antibiome Center), the University of Chicago,...
